학술논문
Which of afatinib and gefitinib/erlotinib is the better EGFR-TKI to be followed by osimertinib?
Document Type
Article
Author
Source
In: Annals of oncology : official journal of the European Society for Medical Oncology . (Annals of oncology : official journal of the European Society for Medical Oncology, 1 October 2018, 29:viii527-viii528)
Subject
Language
English
ISSN
15698041